claimedco.com - the verified startup registry
Versant Ventures
versantventures.com · Basel (Switzerland), San Francisco, New York, San Diego, Toronto, Vancouver · founded 1999 · team 6 Managing Directors, 2 Partners, 10+ Venture Partners, 4-5 Principals (75 employees total per LinkedIn) · Seed through post-IPO; typical check size $1M-$50M; across all funding stages · trust 0/4
Versant Ventures is a global venture capital firm focused on investing in biotechnology companies. Transform academic discoveries into breakthrough therapeutic companies.
This dossier was built by Clark from a public scan on 2026-07-05 and is unclaimed. Is this your startup? Claim it.
Verified facts
| Company Name | Versant Ventures
source: https://versantventures.com |
| Investment Thesis / Tagline | Versant Ventures is a global venture capital firm focused on investing in biotechnology companies. Transform academic discoveries into breakthrough therapeutic companies.
source: https://versantventures.com homepage + F4.fund profile |
| Office Locations | Basel (Switzerland), San Francisco, New York, San Diego, Toronto, Vancouver
source: https://versantventures.com/offices |
| Founded | 1999
source: https://versantventures.com homepage; LinkedIn company page; F4.fund profile |
| Team Size | 6 Managing Directors, 2 Partners, 10+ Venture Partners, 4-5 Principals (75 employees total per LinkedIn)
source: https://www.versantventures.com/team; LinkedIn company page |
| Investment Stage / Check Size | Seed through post-IPO; typical check size $1M-$50M; across all funding stages
source: F4.fund investment thesis profile |
| Founders | Former partners from Brentwood Associates; specifically Beckie Robertson (Founder and General Partner, per The Org)
source: F4.fund profile; The Org (theorg.com/org/versant-ventures/offices/hq) |
| Entity Type / AUM | Biotechnology venture capital firm; $5.5B AUM (website); $2.4B on LinkedIn (discrepancy noted)
source: https://versantventures.com homepage; LinkedIn company page |
| Contact Email | sedelson@versantventures.com
source: BlueRock Therapeutics press release: Bayer and Versant Ventures Join Forces to Launch BluRock Therapeutics (newswirepr.com) |
Open in the registry app →